Glycopyrronium bromide

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Chronic obstructive pulmonary disease

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Call for patient/clinician input open:

November 27, 2012

Brand Name:

Seebri

Project Line:

Reimbursement Review

Project Number:

SR0300-000

Call for patient/clinician input closed:

December 21, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment

Recommendation Type:

List with criteria/condition

Final Recommendation:

May 15, 2013

Last Updated : November 30, 2012